Target intelligence / Profile preview

Imidazoline Receptor (IR)

Target
IR
Molecular classification
Receptor, G protein-coupled receptor (I1), Monoamine oxidase (MAO) allosteric modulator (I2), ATP-sensitive K+ channel modulator (I3, possible)
01

Overview

Imidazoline receptors are a family of nonadrenergic binding sites classified into three main subtypes: I1, I2, and I3. They play diverse roles in various physiological processes, including blood pressure regulation, insulin secretion, pain modulation, and neuroprotection. The precise molecular identities of these receptors remain elusive, and ongoing research aims to fully characterize their structure and function, as well as develop more selective and effective therapeutic agents.

Other names
Imidazoline binding siteI1 receptorI2 receptorI3 receptor
02

Mechanism of action

I1 agonists lower blood pressure by reducing central sympathetic outflow. I2 ligands allosterically modulate monoamine oxidase B (MAO-B). I3 ligands regulate insulin secretion, possibly via ATP-sensitive K+ channels.

03

Biological functions

Signal transductionRegulation of sympathetic toneModulation of monoamine oxidase activityRegulation of insulin secretionNeuroprotectionAnalgesia
04

Disease associations

HypertensionGlaucomaChronic PainDiabetesNeurodegenerative diseaseFibromyalgia
05

Safety considerations

Hypotension (I1 agonists)Side effects related to MAO modulation (I2 ligands)Unknown safety profile for some I2 and I3 ligandsPotential for off-target effects due to incomplete receptor characterization
06

Interacting drugs

Clonidine

9 more in the full profile.

Beyond the preview

Go deeper on Imidazoline Receptor (IR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imidazoline Receptor (IR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call